The rate of prescriptions for ADHD medications rose by 30% during the height of the pandemic, from 2020 to 2022. Most of these new prescriptions were given to people between the ages of 20 and 39. And the prescription rate for those assigned female at birth, including women and some trans people, doubled during this time as well, according to a recent study. Prescriptions for anxiety and depression medications did not rise at a similarly high rate during that time.